Pharmacology and therapeutics of bronchodilators

M Cazzola, CP Page, L Calzetta, MG Matera… - Pharmacological …, 2012 - Elsevier
Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of
the current management of chronic obstructive pulmonary disease (COPD) and are critical in …

Drug-induced urinary retention: incidence, management and prevention

KMC Verhamme, MCJM Sturkenboom, BHC Stricker… - Drug safety, 2008 - Springer
Urinary retention is a condition in which impaired emptying of the bladder results in
postvoidal residual urine. It is generally classified into 'acute'or 'chronic'urinary retention …

BSACI guideline for the diagnosis and management of allergic and non‐allergic rhinitis (Revised Edition 2017; 2007)

GK Scadding, HH Kariyawasam… - Clinical & …, 2017 - Wiley Online Library
This is an updated guideline for the diagnosis and management of allergic and non‐allergic
rhinitis, first published in 2007. It was produced by the Standards of Care Committee of the …

BSACI guidelines for the management of allergic and non‐allergic rhinitis

GK Scadding, SR Durham, R Mirakian… - Clinical & …, 2008 - Wiley Online Library
This guidance for the management of patients with allergic and non‐allergic rhinitis has
been prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy …

Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition

JA Taylor III, GA Kuchel - Journal of the American Geriatrics …, 2006 - Wiley Online Library
Urinary incontinence and other lower urinary tract symptoms exert a major influence on the
health and independence of frail older people. Detrusor underactivity (DU) is defined as a …

Drug-induced bladder and urinary disorders: incidence, prevention and management

MJ Drake, PM Nixon, JP Crew - Drug safety, 1998 - Springer
The bladder is vulnerable to the adverse effects of drugs because of its complex control and
the frequent excretion of drug metabolites in the urine. Incontinence results when bladder …

Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study

A Stephenson, D Seitz, CM Bell… - Archives of Internal …, 2011 - jamanetwork.com
Background Inhaled anticholinergic medications (IACs) are widely used treatments for
chronic obstructive pulmonary disease (COPD). The systemic anticholinergic effects of IAC …

Inhaled anticholinergic drugs and risk of acute urinary retention

ASM Afonso, K Verhamme, BHC Stricker… - BJU …, 2011 - biblio.ugent.be
What's known on the subject? and What does the study add? Inhaled anticholinergic drugs
have been associated with the risk of acute urinary retention (AUR), but this association was …

Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review

YK Loke, S Singh - Therapeutic advances in drug safety, 2013 - journals.sagepub.com
Inhaled anticholinergics (ipratropium bromide and tiotropium bromide) are widely used as
maintenance treatment in chronic obstructive pulmonary disease. Previous studies have …

Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD–role of umeclidinium/vilanterol

M Malerba, JB Morjaria, A Radaeli - International journal of chronic …, 2014 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease
characterized by airflow limitation that is not fully reversible. Bronchodilator therapy is the …